Barry I. Samuels

High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine

Jorge Romaguera, Luis Fayad, Maria Alma Rodriguez et al. · Journal of Clinical Oncology · 2005 · 557 citations · Full text

Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

André Goy, Anas Younes, Peter McLaughlin et al. · Journal of Clinical Oncology · 2004 · 526 citations · Full text

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.

Issa F. Khouri, Jorge Romaguera, Hagop M. Kantarjian et al. · Journal of Clinical Oncology · 1998 · 358 citations

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

Issa F. Khouri, Peter McLaughlin, Rima M. Saliba et al. · Blood · 2008 · 293 citations

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.

Naoto T. Ueno, Gabriela Rondón, Nadeem Q. Mirza et al. · Journal of Clinical Oncology · 1998 · 241 citations